<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34857917</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5403</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Cell death and differentiation</Title><ISOAbbreviation>Cell Death Differ</ISOAbbreviation></Journal><ArticleTitle>Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>1187</StartPage><EndPage>1198</EndPage><MedlinePgn>1187-1198</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41418-021-00910-z</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is caused by selective degeneration of motor neurons in the brain and spinal cord; however, the primary cell death pathway(s) mediating motor neuron demise remain elusive. We recently established that necroptosis, an inflammatory form of regulated cell death, was dispensable for motor neuron death in a mouse model of ALS, implicating other forms of cell death. Here, we confirm these findings in ALS patients, showing a lack of expression of key necroptotic effector proteins in spinal cords. Rather, we uncover evidence for ferroptosis, a recently discovered iron-dependent form of regulated cell death, in ALS. Depletion of glutathione peroxidase 4 (GPX4), an anti-oxidant enzyme and central repressor of ferroptosis, occurred in post-mortem spinal cords of both sporadic and familial ALS patients. GPX4 depletion was also an early and universal feature of spinal cords and brains of transgenic mutant superoxide dismutase 1 (SOD1<sup>G93A</sup>), TDP-43 and C9orf72 mouse models of ALS. GPX4 depletion and ferroptosis were linked to impaired NRF2 signalling and dysregulation of glutathione synthesis and iron-binding proteins. Novel BAC transgenic mice overexpressing human GPX4 exhibited high GPX4 expression localised to spinal motor neurons. Human GPX4 overexpression in SOD1<sup>G93A</sup> mice significantly delayed disease onset, improved locomotor function and prolonged lifespan, which was attributed to attenuated lipid peroxidation and motor neuron preservation. Our study discovers a new role for ferroptosis in mediating motor neuron death in ALS, supporting the use of anti-ferroptotic therapeutic strategies, such as GPX4 pathway induction and upregulation, for ALS treatment.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Taide</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomas</LastName><ForeName>Doris</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perera</LastName><ForeName>Nirma D</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuic</LastName><ForeName>Brittany</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luikinga</LastName><ForeName>Sophia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viden</LastName><ForeName>Aida</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barton</LastName><ForeName>Samantha K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McLean</LastName><ForeName>Catriona A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Anatomical Pathology, Alfred Health, Melbourne, VIC, 3004, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samson</LastName><ForeName>Andr&#xe9; L</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0002-0637-2716</Identifier><AffiliationInfo><Affiliation>The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biology, University of Melbourne, Parkville, VIC, 3050, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Southon</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bush</LastName><ForeName>Ashley I</ForeName><Initials>AI</Initials><Identifier Source="ORCID">0000-0001-8259-9069</Identifier><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>James M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0003-0195-3949</Identifier><AffiliationInfo><Affiliation>The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biology, University of Melbourne, Parkville, VIC, 3050, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Bradley J</ForeName><Initials>BJ</Initials><Identifier Source="ORCID">0000-0001-6580-7655</Identifier><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, 3052, Australia. bradley.turner@florey.edu.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Perron Institute for Neurological and Translational Science, Queen Elizabeth Medical Centre, Nedlands, WA, Australia. bradley.turner@florey.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Differ</MedlineTA><NlmUniqueID>9437445</NlmUniqueID><ISSNLinking>1350-9047</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000079403" MajorTopicYN="Y">Ferroptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>ALS and JMM contribute to a programme developing inhibitors of necroptosis with Anaxis Pharma Pty Ltd.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>56</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34857917</ArticleId><ArticleId IdType="pmc">PMC9177596</ArticleId><ArticleId IdType="doi">10.1038/s41418-021-00910-z</ArticleId><ArticleId IdType="pii">10.1038/s41418-021-00910-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;337:162&#x2013;72. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25:486&#x2013;541. doi: 10.1038/s41418-017-0012-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-017-0012-4</ArticleId><ArticleId IdType="pmc">PMC5864239</ArticleId><ArticleId IdType="pubmed">29362479</ArticleId></ArticleIdList></Reference><Reference><Citation>Aebischer J, Bernard-Marissal N, Pettmann B, Raoul C. Death receptors in the selective degeneration of motoneurons in amyotrophic lateral sclerosis. J Neurodegener Dis. 2013;2013:746845. 10.1155/2013/746845.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4437334</ArticleId><ArticleId IdType="pubmed">26316997</ArticleId></ArticleIdList></Reference><Reference><Citation>Re DB, Le Verche V, Yu C, Amoroso MW, Politi KA, Phani S, et al. Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron. 2014;81:1001&#x2013;8. doi: 10.1016/j.neuron.2014.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.011</ArticleId><ArticleId IdType="pmc">PMC3951532</ArticleId><ArticleId IdType="pubmed">24508385</ArticleId></ArticleIdList></Reference><Reference><Citation>Dzhashiashvili Y, Monckton CP, Shah HS, Kunjamma RB, Popko B. The UPR-PERK pathway is not a promising therapeutic target for mutant SOD1-induced ALS. Neurobiol Dis. 2019;127:527&#x2013;44. doi: 10.1016/j.nbd.2019.03.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.03.024</ArticleId><ArticleId IdType="pmc">PMC6588429</ArticleId><ArticleId IdType="pubmed">30923003</ArticleId></ArticleIdList></Reference><Reference><Citation>Samson AL, Garnish SE, Hildebrand JM, Murphy JM. Location, location, location: a compartmentalized view of TNF-induced necroptotic signaling. Sci Signal. 2021;14:eabc6178. 10.1126/scisignal.abc6178.</Citation><ArticleIdList><ArticleId IdType="pubmed">33531383</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevin M, S&#xe9;bire G. Necroptosis in ALS: a hot topic in-progress. Cell Death Discov. 2021;7:1. doi: 10.1038/s41420-021-00458-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-021-00458-4</ArticleId><ArticleId IdType="pmc">PMC8046817</ArticleId><ArticleId IdType="pubmed">33854042</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Y, Ofengeim D, Najafov A, Das S, Saberi S, Li Y, et al. RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science. 2016;353:603&#x2013;8. doi: 10.1126/science.aaf6803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf6803</ArticleId><ArticleId IdType="pmc">PMC5444917</ArticleId><ArticleId IdType="pubmed">27493188</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez S, Varfolomeev E, Brendza R, Stark K, Tea J, Imperio J, et al. Genetic inactivation of RIP1 kinase does not ameliorate disease in a mouse model of ALS. Cell Death Differ. 2021;28:915&#x2013;31. doi: 10.1038/s41418-020-00625-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-020-00625-7</ArticleId><ArticleId IdType="pmc">PMC7937687</ArticleId><ArticleId IdType="pubmed">32994544</ArticleId></ArticleIdList></Reference><Reference><Citation>Dermentzaki G, Politi KA, Lu L, Mishra V, P&#xe9;rez-Torres EJ, Sosunov AA, et al. Deletion of Ripk3 prevents motor neuron death in Vitro but not in Vivo. eNeuro. 2019;6:1&#x2013;16.. doi: 10.1523/ENEURO.0308-18.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/ENEURO.0308-18.2018</ArticleId><ArticleId IdType="pmc">PMC6391588</ArticleId><ArticleId IdType="pubmed">30815534</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Perera ND, Chiam MDF, Cuic B, Wanniarachchillage N, Tomas D, et al. Necroptosis is dispensable for motor neuron degeneration in a mouse model of ALS. Cell Death Differ. 2020;27:1728&#x2013;39. doi: 10.1038/s41418-019-0457-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-019-0457-8</ArticleId><ArticleId IdType="pmc">PMC7206015</ArticleId><ArticleId IdType="pubmed">31745214</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon SJ, Stockwell BR. The role of iron and reactive oxygen species in cell death. Nat Chem Biol. 2014;10:9&#x2013;17. doi: 10.1038/nchembio.1416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.1416</ArticleId><ArticleId IdType="pubmed">24346035</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Li J, Kang R, Klionsky DJ, Tang D. Ferroptosis: machinery and regulation. Autophagy. 2021;17:2054&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8496712</ArticleId><ArticleId IdType="pubmed">32804006</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107&#x2013;25.. doi: 10.1038/s41422-020-00441-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-00441-1</ArticleId><ArticleId IdType="pmc">PMC8026611</ArticleId><ArticleId IdType="pubmed">33268902</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh HJ, et al. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy. 2016;12:1425&#x2013;8. doi: 10.1080/15548627.2016.1187366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2016.1187366</ArticleId><ArticleId IdType="pmc">PMC4968231</ArticleId><ArticleId IdType="pubmed">27245739</ArticleId></ArticleIdList></Reference><Reference><Citation>Park E, Chung SW. ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation. Cell Death Dis. 2019;10:822. doi: 10.1038/s41419-019-2064-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-2064-5</ArticleId><ArticleId IdType="pmc">PMC6817894</ArticleId><ArticleId IdType="pubmed">31659150</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth EK, Conrad M, Winterer J, Wozny C, Carlson BA, Roth S, et al. Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurodegeneration. FASEB J. 2010;24:844&#x2013;52. doi: 10.1096/fj.09-143974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.09-143974</ArticleId><ArticleId IdType="pmc">PMC2830140</ArticleId><ArticleId IdType="pubmed">19890015</ArticleId></ArticleIdList></Reference><Reference><Citation>Seiler A, Schneider M, F&#xf6;rster H, Roth S, Wirth EK, Culmsee C, et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 2008;8:237&#x2013;48. doi: 10.1016/j.cmet.2008.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2008.07.005</ArticleId><ArticleId IdType="pubmed">18762024</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang WS, Sriramaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156:317&#x2013;31. 10.1016/j.cell.2013.12.010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4076414</ArticleId><ArticleId IdType="pubmed">24439385</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16:1180&#x2013;91. 10.1038/ncb3064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4894846</ArticleId><ArticleId IdType="pubmed">25402683</ArticleId></ArticleIdList></Reference><Reference><Citation>Oba H, Araki T, Ohtomo K, Monzawa S, Uchiyama G, Koizumi K, et al. Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology. 1993;189:843&#x2013;6. doi: 10.1148/radiology.189.3.8234713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiology.189.3.8234713</ArticleId><ArticleId IdType="pubmed">8234713</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasarskis EJ, Tandon L, Lovell MA, Ehmann WD. Aluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: a preliminary study. J Neurol Sci. 1995;130:203&#x2013;8. doi: 10.1016/0022-510X(95)00037-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(95)00037-3</ArticleId><ArticleId IdType="pubmed">8586987</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh YJ, Rathore KI, Schulz K, Ponka P, Arosio P, David S. Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis. J Neurosci. 2009;29:610&#x2013;19. doi: 10.1523/JNEUROSCI.5443-08.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5443-08.2009</ArticleId><ArticleId IdType="pmc">PMC6665152</ArticleId><ArticleId IdType="pubmed">19158288</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi IY, Lee P, Statland J, McVey A, Dimachkie M, Brooks W, et al. Reduction in cerebral antioxidant, glutathione (GSH), in patients with ALS: a preliminary study. Neurology. 2015;84:P6.105.</Citation></Reference><Reference><Citation>Khan M, Sekhon B, Jatana M, Giri S, Gilg AG, Sekhon C, et al. Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke. J Neurosci Res. 2004;76:519&#x2013;27. doi: 10.1002/jnr.20087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.20087</ArticleId><ArticleId IdType="pubmed">15114624</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi L, Ke Y, Luo C, Gozal D, Liu R. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo. Neuroscience. 2007;144:991&#x2013;1003. doi: 10.1016/j.neuroscience.2006.09.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2006.09.064</ArticleId><ArticleId IdType="pmc">PMC1944995</ArticleId><ArticleId IdType="pubmed">17150307</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesci P, Za&#xef;di S, Lobsiger CS, Millecamps S, Escartin C, Seilhean D, et al. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice. Brain. 2015;138:53&#x2013;68. doi: 10.1093/brain/awu312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu312</ArticleId><ArticleId IdType="pmc">PMC4441079</ArticleId><ArticleId IdType="pubmed">25384799</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrante RJ, Shinobu LA, Schulz JB, Matthews RT, Thomas CE, Kowall NW, et al. Increased 3-Nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation. Ann Neurol. 1997;42:326&#x2013;34. doi: 10.1002/ana.410420309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410420309</ArticleId><ArticleId IdType="pubmed">9307254</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen WA, Fu W, Keller JN, Markesbery WR, Appel S, Smith RG, et al. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann Neurol. 1998;44:819&#x2013;24. doi: 10.1002/ana.410440518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410440518</ArticleId><ArticleId IdType="pubmed">9818940</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Hambright WS, Na R, Ran Q. Ablation of the ferroptosis inhibitor glutathione peroxidase 4 in neurons results in rapid motor neuron degeneration and paralysis. J Biol Chem. 2015;290:28097&#x2013;106. doi: 10.1074/jbc.M115.680090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.680090</ArticleId><ArticleId IdType="pmc">PMC4653669</ArticleId><ArticleId IdType="pubmed">26400084</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Na R, Danae McLane K, Thompson CS, Gao J, Wang X, et al. Overexpression of ferroptosis defense enzyme Gpx4 retards motor neuron disease of SOD1G93A mice. Sci Rep. 2021;11:1&#x2013;13.. doi: 10.1038/s41598-020-79139-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-79139-8</ArticleId><ArticleId IdType="pmc">PMC8213805</ArticleId><ArticleId IdType="pubmed">34145375</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott S, Kranz JE, Cole J, Lincecum JM, Thompson K, Kelly N, et al. Design, power, and interpretation of studies in the standard murine model of ALS. Amyotroph Lateral Scler. 2008;9:4&#x2013;15. doi: 10.1080/17482960701856300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701856300</ArticleId><ArticleId IdType="pubmed">18273714</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrie EJ, Sandow JJ, Jacobsen AV, Smith BJ, Griffin MDW, Lucet IS, et al. Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis. Nat Commun. 2018;9:2422. doi: 10.1038/s41467-018-04714-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04714-7</ArticleId><ArticleId IdType="pmc">PMC6013482</ArticleId><ArticleId IdType="pubmed">29930286</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu CL, Nydes M, Shanley KL, Morales Pantoja IE, Howard TA, Bizzozero OA. Reduced expression of the ferroptosis inhibitor glutathione peroxidase-4 in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurochem. 2019;148:426&#x2013;39. doi: 10.1111/jnc.14604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14604</ArticleId><ArticleId IdType="pmc">PMC6347488</ArticleId><ArticleId IdType="pubmed">30289974</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao X, Huang X, Zhou Z, Lin X. An improvement of the 2&#x2c6;(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath. 2013;3:71&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4280562</ArticleId><ArticleId IdType="pubmed">25558171</ArticleId></ArticleIdList></Reference><Reference><Citation>Samson AL, Zhang Y, Geoghegan ND, Gavin XJ, Davies KA, Mlodzianoski MJ, et al. MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis. Nat Commun. 2020;11:3151. doi: 10.1038/s41467-020-16887-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-16887-1</ArticleId><ArticleId IdType="pmc">PMC7305196</ArticleId><ArticleId IdType="pubmed">32561730</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon SJ, Stockwell BR. The hallmarks of ferroptosis. Annu Rev Cancer Biol. 2019;3:35&#x2013;54. doi: 10.1146/annurev-cancerbio-030518-055844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cancerbio-030518-055844</ArticleId></ArticleIdList></Reference><Reference><Citation>Forcina GC, Dixon SJ. GPX4 at the crossroads of lipid homeostasis and ferroptosis. Proteomics. 2019;19:1&#x2013;11. doi: 10.1002/pmic.201800311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.201800311</ArticleId><ArticleId IdType="pubmed">30888116</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei P, Bai T, Sun Y. Mechanisms of ferroptosis and relations with regulated cell death: a review. Front Physiol. 2019;10:1&#x2013;13..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6399426</ArticleId><ArticleId IdType="pubmed">30863316</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding H, Chen S, Pan X, Dai X, Pan G, Li Z, et al. Transferrin receptor 1 ablation in satellite cells impedes skeletal muscle regeneration through activation of ferroptosis. J Cachexia Sarcopenia Muscle. 2021;12:746&#x2013;68. doi: 10.1002/jcsm.12700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12700</ArticleId><ArticleId IdType="pmc">PMC8200440</ArticleId><ArticleId IdType="pubmed">33955709</ArticleId></ArticleIdList></Reference><Reference><Citation>Ran Q, Liang H, Gu M, Qi W, Walter CA, Roberts LJ, et al. Transgenic mice overexpressing glutathione peroxidase 4 are protected against oxidative stress-induced apoptosis. J Biol Chem. 2004;279:55137&#x2013;46. doi: 10.1074/jbc.M410387200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M410387200</ArticleId><ArticleId IdType="pubmed">15496407</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060&#x2013;72. doi: 10.1016/j.cell.2012.03.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.03.042</ArticleId><ArticleId IdType="pmc">PMC3367386</ArticleId><ArticleId IdType="pubmed">22632970</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuo T, Adachi-Tominari K, Sano O, Kamei T, Nogami M, Ogi K, et al. Involvement of ferroptosis in human motor neuron cell death. Biochem Biophys Res Commun. 2021;566:24&#x2013;29. doi: 10.1016/j.bbrc.2021.05.095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2021.05.095</ArticleId><ArticleId IdType="pubmed">34111668</ArticleId></ArticleIdList></Reference><Reference><Citation>Devos D, Moreau C, Kyheng M, Gar&#xe7;on G, Rolland AS, Blasco H, et al. Author correction: A ferroptosis-based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis (Scientific Reports, (2019), 9, 1, (2918) Sci Rep. 2020;10:58956. doi: 10.1038/s41598-020-58956-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-58956-x</ArticleId><ArticleId IdType="pmc">PMC6393674</ArticleId><ArticleId IdType="pubmed">30814647</ArticleId></ArticleIdList></Reference><Reference><Citation>Rickard JA, O&#x2019;Donnell JA, Evans JM, Lalaoui N, Poh AR, Rogers T, et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell. 2014;157:1175&#x2013;88. doi: 10.1016/j.cell.2014.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.04.019</ArticleId><ArticleId IdType="pubmed">24813849</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy JM, Czabotar PE, Hildebrand JM, Lucet IS, Zhang JG, Alvarez-Diaz S, et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity. 2013;39:443&#x2013;53. doi: 10.1016/j.immuni.2013.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2013.06.018</ArticleId><ArticleId IdType="pubmed">24012422</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton K, Sun X, Dixit VM. Kinase RIP3 is dispensable for normal NF-&#x3ba;Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and toll-like receptors 2 and 4. Mol Cell Biol. 2004;24:1464&#x2013;9. doi: 10.1128/MCB.24.4.1464-1469.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.24.4.1464-1469.2004</ArticleId><ArticleId IdType="pmc">PMC344190</ArticleId><ArticleId IdType="pubmed">14749364</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprimont L, Janssen P, De Swert K, Van Bulck M, Rooman I, Gilloteaux J, et al. Cystine&#x2013;glutamate antiporter deletion accelerates motor recovery and improves histological outcomes following spinal cord injury in mice. Sci Rep. 2021;11:1&#x2013;15.. doi: 10.1038/s41598-021-91698-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-91698-y</ArticleId><ArticleId IdType="pmc">PMC8190126</ArticleId><ArticleId IdType="pubmed">34108554</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, Geng Y, Lu X, Shi Y, Wu G, Zhang M, et al. Chaperone-mediated autophagy is involved in the execution of ferroptosis. Proc Natl Acad Sci USA. 2019;116:2996&#x2013;3005. doi: 10.1073/pnas.1819728116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1819728116</ArticleId><ArticleId IdType="pmc">PMC6386716</ArticleId><ArticleId IdType="pubmed">30718432</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellinger FP, Bellinger MT, Seale LA, Takemoto AS, Raman AV, Miki T, et al. Glutathione peroxidase 4 is associated with neuromelanin in substantia nigra and dystrophic axons in putamen of Parkinson&#x2019;s brain. Mol Neurodegener. 2011;6:8. 10.1186/1750-1326-6-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3037910</ArticleId><ArticleId IdType="pubmed">21255396</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Wu Y, Yuan S, Zhang P, Zhang J, Li H, et al. Glutathione peroxidase 4 participates in secondary brain injury through mediating ferroptosis in a rat model of intracerebral hemorrhage. Brain Res. 2018;1701:112&#x2013;25. doi: 10.1016/j.brainres.2018.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.09.012</ArticleId><ArticleId IdType="pubmed">30205109</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389&#x2013;92. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Cudkowicz ME, Pastusza KA, Sapp PC, Mathews RK, Leahy J, Pasinelli P, et al. Survival in transgenic ALS mice does not vary with CNS glutathione peroxidase activity. Neurology. 2002;59:729&#x2013;34. doi: 10.1212/WNL.59.5.729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.59.5.729</ArticleId><ArticleId IdType="pubmed">12221165</ArticleId></ArticleIdList></Reference><Reference><Citation>Alim I, Caulfield JT, Chen Y, Swarup V, Geschwind DH, Ivanova E, et al. Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke. Cell. 2019;177:1262&#x2013;79.e25. doi: 10.1016/j.cell.2019.03.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.03.032</ArticleId><ArticleId IdType="pubmed">31056284</ArticleId></ArticleIdList></Reference><Reference><Citation>Soon CPW, Donnelly PS, Turner BJ, Hung LW, Crouch PJ, Sherratt NA, et al. Diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (Cu II(atsm)) protects against peroxynitrite-induced nitrosative damage and prolongs survival in amyotrophic lateral sclerosis mouse model. J Biol Chem. 2011;286:44035&#x2013;44. doi: 10.1074/jbc.M111.274407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.274407</ArticleId><ArticleId IdType="pmc">PMC3243559</ArticleId><ArticleId IdType="pubmed">22033929</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts BR, Lim NKH, McAllum EJ, Donnelly PS, Hare DJ, Doble PA, et al. Oral treatment with CuII(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci. 2014;34:8021&#x2013;31. doi: 10.1523/JNEUROSCI.4196-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4196-13.2014</ArticleId><ArticleId IdType="pmc">PMC6608261</ArticleId><ArticleId IdType="pubmed">24899723</ArticleId></ArticleIdList></Reference><Reference><Citation>Southon A, Szostak K, Acevedo KM, Dent KA, Volitakis I, Belaidi AA, et al. CuII(atsm) inhibits ferroptosis: Implications for treatment of neurodegenerative disease. Br J Pharm. 2020;177:656&#x2013;67.. doi: 10.1111/bph.14881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.14881</ArticleId><ArticleId IdType="pmc">PMC7012947</ArticleId><ArticleId IdType="pubmed">31655003</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JK, Shin JH, Gwag BJ, Choi EJ. Iron accumulation promotes TACE-mediated TNF-&#x3b1; secretion and neurodegeneration in a mouse model of ALS. Neurobiol Dis. 2015;80:63&#x2013;69. doi: 10.1016/j.nbd.2015.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.05.009</ArticleId><ArticleId IdType="pubmed">26002422</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreau C, Danel V, Devedjian JC, Grolez G, Timmerman K, Laloux C, et al. Could conservative iron chelation lead to neuroprotection in amyotrophic lateral sclerosis? Antioxid Redox Signal. 2018;29:742&#x2013;8. doi: 10.1089/ars.2017.7493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2017.7493</ArticleId><ArticleId IdType="pmc">PMC6067092</ArticleId><ArticleId IdType="pubmed">29287521</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>